Potentiation of the antiviral activity of poly r(A-U) by riboflavin, FAD and FMN

Cell Biol Int Rep. 1989 Feb;13(2):215-22. doi: 10.1016/0309-1651(89)90068-4.

Abstract

The role of riboflavin (RFN), FAD or FMN in modulating the antiviral activity of poly r(A-U) was examined by the human foreskin fibroblast-vesicular stomatitis virus bioassay in which the concentrations of poly r(A-U) was fixed at 0.1 mM or 0.2 mM while the riboflavin, FAD or FMN concentration was varied to produce variable RFN (or FAD or FMN)/ribonucleotide ratios ranging from 1/16 to 2/1. Riboflavin, FAD and FMN tested individually did not exhibit any antiviral activity, while poly r(A-U) alone exhibited antiviral activity. When poly r(A-U) was combined with riboflavin, FAD or FMN, the antiviral activity was potentiated seven- to twelve-fold at RFN (or FAD or FMN)/ribonucleotide ratios in the region of 1/4.

MeSH terms

  • Cytopathogenic Effect, Viral
  • Drug Synergism
  • Fibroblasts
  • Flavin Mononucleotide / pharmacology*
  • Flavin-Adenine Dinucleotide / pharmacology*
  • Humans
  • Interferons / biosynthesis
  • Male
  • Poly A-U / pharmacology*
  • Riboflavin / pharmacology*
  • Vesicular stomatitis Indiana virus / drug effects*
  • Vesicular stomatitis Indiana virus / physiology
  • Viral Plaque Assay

Substances

  • Flavin-Adenine Dinucleotide
  • Poly A-U
  • Flavin Mononucleotide
  • Interferons
  • Riboflavin